Skip to main content

and
  1. Article

    Open Access

    Mature human induced pluripotent stem cell-derived cardiomyocytes promote angiogenesis through alpha-B crystallin

    Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) can be used to treat heart diseases; however, the optimal maturity of hiPSC-CMs for effective regenerative medicine remains unclear. We ai...

    Yuki Tanaka, Shin Kadota, Jian Zhao, Hideki Kobayashi in Stem Cell Research & Therapy (2023)

  2. No Access

    Chapter

    Clinical Application of iPSC-Derived Cardiomyocytes in Patients with Advanced Heart Failure

    Restoration of damaged cardiac tissues via supplementation with functional cardiomyocytes is an ideal medical treatment for advanced heart failure. Because human induced pluripotent stem cells (hiPSCs) can the...

    Jun Fujita, Shugo Tohyama, Hideaki Kanazawa in Advanced Technologies in Cardiovascular Bi… (2022)

  3. Article

    Open Access

    Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes

    Pluripotent stem cells (PSCs) exhibit promising application in regenerative therapy, drug discovery, and disease modeling. While several protocols for differentiating somatic cells from PSCs exist, their use i...

    Sho Tanosaki, Shugo Tohyama, Yoshikazu Kishino, Jun Fujita in Inflammation and Regeneration (2021)

  4. No Access

    Protocol

    A Method for Cardiac Differentiation, Purification, and Cardiac Spheroid Production of Human Induced Pluripotent Stem Cells

    Human induced pluripotent stem cells (hiPSCs) are one of the most promising cell sources for regenerative medicine. To realize the promise of hiPSCs for cardiac regenerative therapy, three major obstacles must...

    Yuika Morita, Shugo Tohyama, Jun Fujita in Pluripotent Stem-Cell Derived Cardiomyocyt… (2021)

  5. Article

    Open Access

    Increased predominance of the matured ventricular subtype in embryonic stem cell-derived cardiomyocytes in vivo

    Accumulating evidence suggests that human pluripotent stem cell-derived cardiomyocytes can affect “heart regeneration”, replacing injured cardiac scar tissue with concomitant electrical integration. However, e...

    Hajime Ichimura, Shin Kadota, Toshihide Kashihara, Mitsuhiko Yamada in Scientific Reports (2020)

  6. Article

    Open Access

    Toward the realization of cardiac regenerative medicine using pluripotent stem cells

    Heart transplantation (HT) is the only radical treatment available for patients with end-stage heart failure that is refractory to optimal medical treatment and device therapies. However, HT as a therapeutic o...

    Yoshikazu Kishino, Jun Fujita, Shugo Tohyama, Marina Okada in Inflammation and Regeneration (2020)

  7. Article

    Open Access

    An effective detachment system for human induced pluripotent stem cells cultured on multilayered cultivation substrates using resonance vibrations

    Clinical application of human induced pluripotent stem cells (hiPSCs) has been hampered by the lack of a practical, scalable culture system. Stacked culture plates (SCPs) have recently attracted attention. How...

    Yusuke Terao, Yuta Kurashina, Shugo Tohyama, Yuki Fukuma in Scientific Reports (2019)

  8. Article

    Open Access

    Emerin plays a crucial role in nuclear invagination and in the nuclear calcium transient

    Alteration of the nuclear Ca2+ transient is an early event in cardiac remodeling. Regulation of the nuclear Ca2+ transient is partly independent of the cytosolic Ca2+ transient in cardiomyocytes. One nuclear memb...

    Masaya Shimojima, Shinsuke Yuasa, Chikaaki Motoda, Gakuto Yozu in Scientific Reports (2017)

  9. Article

    Open Access

    Manipulation of Pluripotent Stem Cell Metabolism for Clinical Application

    Pluripotent stem cells (PSCs) have the capacity to differentiate into various types of cells, and are promising cell sources for regenerative therapy and drug screening. However, to realize the clinical applic...

    Shugo Tohyama, Sho Tanosaki, Shota Someya, Jun Fujita in Current Stem Cell Reports (2017)

  10. Article

    Open Access

    Cryoinjury-induced acute myocardial infarction model and ameroid constrictor-induced ischemic heart disease model in adult micro-mini pigs for preclinical studies

    Coronary artery diseases (CAD) are the most commonly occurring disorders in the developed countries. Development of new therapeutics and their success in clinical studies require confirmation of therapeutic ef...

    Akinori Hirano, Jun Fujita, Hideaki Kanazawa in Translational Medicine Communications (2017)

  11. No Access

    Chapter

    Purification of Pluripotent Stem Cell-Derived Cardiomyocytes for Safe Cardiac Regeneration

    Human pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and induced PSCs (iPSCs), have the potential to differentiate into various cells types and may be used as cell sources for regenerativ...

    Shugo Tohyama, Keiichi Fukuda in Cardiac Regeneration (2017)

  12. No Access

    Chapter

    Road to Heart Regeneration with Induced Pluripotent Stem Cells

    Restoration of cardiac function is the most desirable treatment of severe heart failure. However, effective regenerative therapy for the lost cardiomyocytes is currently an unmet medical need. Induced pluripot...

    Jun Fujita, Shugo Tohyama, Kazuaki Nakajima in Liver, Lung and Heart Regeneration (2017)

  13. Article

    Open Access

    ANGPTL2 activity in cardiac pathologies accelerates heart failure by perturbing cardiac function and energy metabolism

    A cardioprotective response that alters ventricular contractility or promotes cardiomyocyte enlargement occurs with increased workload in conditions such as hypertension. When that response is excessive, patho...

    Zhe Tian, Keishi Miyata, Tsuyoshi Kadomatsu, Haruki Horiguchi in Nature Communications (2016)

  14. No Access

    Protocol

    Patient-Specific Induced Pluripotent Stem Cell Models: Characterization of iPS Cell-Derived Cardiomyocytes

    Despite significant advances in medical treatment, cardiovascular disease is still a major cause of morbidity and mortality in advanced countries. To improve the outcome, the further promotion of basic cardiov...

    Toru Egashira, Shinsuke Yuasa M.D., Ph.D. in Patient-Specific Induced Pluripotent Stem … (2016)

  15. Chapter

    Future Treatment of Heart Failure Using Human iPSC-Derived Cardiomyocytes

    Heart transplantation can drastically improve survival in patients with a failing heart; however, the shortage of donor hearts remains a serious problem with this treatment strategy and the successful clinical...

    Shugo Tohyama, Keiichi Fukuda in Etiology and Morphogenesis of Congenital Heart Disease (2016)

  16. Article

    Erratum: G-CSF supports long-term muscle regeneration in mouse models of muscular dystrophy

    Nature Communications 6: Article number: 6745 (2015); Published 13 April 2015; Updated 18 June 2015. The immunofluorescence images in Fig. 1b of the PDF version of this Article were inadvertently duplicated fr...

    Nozomi Hayashiji, Shinsuke Yuasa, Yuko Miyagoe-Suzuki, Mie Hara in Nature Communications (2015)

  17. No Access

    Article

    G-CSF supports long-term muscle regeneration in mouse models of muscular dystrophy

    Duchenne muscular dystrophy (DMD) is a chronic and life-threatening disease that is initially supported by muscle regeneration but eventually shows satellite cell exhaustion and muscular dysfunction. The life-...

    Nozomi Hayashiji, Shinsuke Yuasa, Yuko Miyagoe-Suzuki, Mie Hara in Nature Communications (2015)

  18. No Access

    Article

    Nongenetic method for purifying stem cell–derived cardiomyocytes

    Staining with a mitochondrial dye permits high-purity isolation of cardiomyocytes from embryonic and induced pluripotent stem cells of several species, without genetic modification.

    Fumiyuki Hattori, Hao Chen, Hiromi Yamashita, Shugo Tohyama in Nature Methods (2010)

  19. Article

    Open Access

    Periodontal disease and atherosclerosis from the viewpoint of the relationship between community periodontal index of treatment needs and brachial-ankle pulse wave velocity

    It has been suggested that periodontal disease may be an independent risk factor for the development of atherosclerosis. However, the relationship between periodontal disease and atherosclerosis has not been f...

    Koichi Miyaki, Katsunori Masaki, Mariko Naito, Toru Naito, Keika Hoshi in BMC Public Health (2006)